Download PDFPDF
Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Future implications

    The authors rightly point out in their introduction that there is evidence (reference 12 Gargiullo P et al N Engl J Med 2007; 356:1121-9) of loss of vaccine-induced immunity over time, and that Australia will likely have to adopt a two-dose varicella schedule, which is not the case currently. I wonder if the authors have any opinion on how this will impact future maternity care in 15-20 years time and whether this will see...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Congenital and neonatal varicella in the United Kingdom
    • Janet E Berrington, Consultant neonatal paediatrician
    • Other Contributors:
      • Eleri Williams, Nicholas Embleton, Julia Clark

    We note with interest the paper from Khandaker (1) and colleagues on the reduction of congenital and neonatal varicella infections following the introduction of immunisation of 18 month old children in Australia from 2005. Using surveillance methodology similar to that of the British Paediatric Surveillance Unit (BPSU) rates of congenital varicella (per 100,000 live births with 95% CI) have fallen from 0.8 (0.3 to 1.8) t...

    Show More
    Conflict of Interest:
    None declared.